los angeles times article new treatment sma type promising news i believe lead additional breakthroughs type sma different sbma kennedy disease antisense technology used progressive disorders could bridge treatment excerpt times article read entire article following link ionis shares leap drug trial goes well ends early option spinal muscular atrophy occurs births caused mutations gene reduce production protein needed survival movement controlling spinal neurons nusinersen increases production protein closely related gene altering rna made gene translated protein done antisense technology field pioneered ionis drugs based antisense technology meant block change targeted genetic instructions delivered rna affect making proteins building blocks life instance could block certain mutations resulting protein synthesis causes unwanted medical condition nusinersen granted orphan drug status european union indicating shows promise treating rare disease condition designated fast track review united states image slideshare net pooranachithraflowry antisense therapy